Los Angeles Business Journal

Amgen Workers Helped U.S. in Marketing Inquiry

Thursday, December 20, 2012

Undercover work by an Amgen Inc. sales rep, and information provided by other whistleblowers, led to Amgen’s agreement this week to pay $762 million to settle federal investigations regarding the marketing of some of its top-selling drugs, the New York Times reports.